Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Androgens may increase arrhythmias in Brugada Syndrome, while Finasteride could reduce them.

3α‐OH‐DHP is essential for reducing nerve activity related to blood pressure control during pregnancy.

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

AVT is highly conserved and may have antimicrobial properties.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Naltrexone did not significantly reduce hair pulling but improved cognitive flexibility.

PEA reduces pain by increasing neurosteroid synthesis in the spinal cord.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

PDRN helps repair tissue and improve wound healing with a high safety profile.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Combining sodium valproate with other epilepsy drugs increases ammonia levels and side effects.

TRPV3 channels are involved in skin processes and are affected by shear stress, influencing itch and mechanotransduction.

Certain drugs can cause early hair growth in mice by affecting the nerves.

New drugs like N-acetylcysteine and dronabinol show promise for treating hair-pulling disorder.

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Virtual reality can reduce pain during scalp injections.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

Certain substances can decrease or increase exploratory behavior in rodents.

In late pregnancy, allopregnanolone reduces stress responses in rats by affecting brain chemicals.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

Ovulation inhibitors effectively treat menstrual issues and improve fertility but can have side effects.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

Breathing in newborn rats is affected differently by hormones based on their sex.